22ND CENTURY GROUP INC (XXII) was one of the Russell 2000's biggest losers for August 27 as the stock slid 15.14% to $2.69, a loss of $0.48 per share. Starting at an opening price of $3.23 a share, the stock traded between $1.90 and $3.27 over the course of the trading day. Volume was 5,562,200 shares over 13,332 trades, against an average daily volume of 307,171 shares and a total float of 59,601,688.
The losses send 22ND CENTURY GROUP INC down to a market cap of $160,328,541. In the last year, 22ND CENTURY GROUP INC has traded between $6.36 and $0.87, and its 50-day SMA is currently $2.94 and 200-day SMA is $2.73.
The stock's P/S ratio is 24.40, P/B ratio is 20.70, and P/FCF ratio is -235.30.
For a full analysis of 22ND CENTURY GROUP INC, check out Equities.com's E.V.A. report.
22nd Century Group, Inc. is a plant biotechnology company focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.
22ND CENTURY GROUP INC, led by CEO Joseph Pandolfino, has 9 employees and is headquartered in Clarence, NY.
One of the most effective tools for tracking the market for small-cap stocks is the Russell 2000, the nation's leading small-cap index created by industry stalwart Russell Investments. Unlike the well-known Dow Jones Industrial Average (DJIA) and S&P 500, Russell's indices eschew committee selection in favor of a more objective, rules-based system for selecting index membership.
The broad-based Russell 3000, which is meant to cover the stock market as a whole, is simply the 3,000 companies with the largest market cap in the United States. The Russell 2000 is then just the bottom 2,000 companies of that index, offering a look at those small-cap companies with smaller market caps. It makes for an unbiased overview of the small-cap stocks that can help any investor get a better sense of what the market is doing and where it might be headed.
For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.
All data provided by QuoteMedia and was accurate as of 4.30PM.